Literature DB >> 9467983

Review article: How relevant to human inflammatory bowel disease are current animal models of intestinal inflammation?

R B Sartor1.   

Abstract

New rodent models of chronic intestinal inflammation are mediated by a TH1-cell and macrophage dominated immune response to luminal bacterial constituents. The pathology of these spontaneous and induced models differ widely and caution is needed when assessing the comparative aspects of such animal models and human inflammatory bowel diseases (IBD). Considerable immunological and therapeutic evidence suggests that chronic and immune-mediated models are relevant in human IBD and that pathogenic principles are similar. However, animal models have not been able to duplicate exactly the pathological characteristics of ulcerative colitis or Crohn's disease, indicating a need for caution in extrapolating data from experimental models to human IBD.

Entities:  

Mesh:

Year:  1997        PMID: 9467983     DOI: 10.1111/j.1365-2036.1997.tb00813.x

Source DB:  PubMed          Journal:  Aliment Pharmacol Ther        ISSN: 0269-2813            Impact factor:   8.171


  10 in total

Review 1.  Evaluation of new therapies for inflammatory bowel disease.

Authors:  E Carty; D S Rampton
Journal:  Br J Clin Pharmacol       Date:  2003-10       Impact factor: 4.335

2.  Exacerbation of murine ileitis by Toll-like receptor 4 mediated sensing of lipopolysaccharide from commensal Escherichia coli.

Authors:  M M Heimesaat; A Fischer; H-K Jahn; J Niebergall; M Freudenberg; M Blaut; O Liesenfeld; R R Schumann; U B Göbel; S Bereswill
Journal:  Gut       Date:  2007-01-25       Impact factor: 23.059

3.  High incidence of inflammatory bowel disease with improved hygiene and failure to get human-like IBD in laboratory animals.

Authors:  Xiaofa Qin
Journal:  World J Gastroenterol       Date:  2007-06-21       Impact factor: 5.742

4.  Proinflammatory and anti-inflammatory cytokines present in the acute phase of experimental colitis treated with Saccharomyces boulardii.

Authors:  Nathália Nahas Grijó; Ricardo Carneiro Borra; Vera Lucia Sdepanian
Journal:  Dig Dis Sci       Date:  2009-12-09       Impact factor: 3.199

5.  Oral administration of avian tumor necrosis factor antibodies effectively treats experimental colitis in rats.

Authors:  K L Worledge; R Godiska; T A Barrett; J A Kink
Journal:  Dig Dis Sci       Date:  2000-12       Impact factor: 3.199

Review 6.  Human Relevance of Preclinical Studies on the Skeletal Impact of Inflammatory Bowel Disease: A Systematic Review and Meta-Analysis.

Authors:  Swati Rajput; Poonam Mehta; Monika Mittal; Singh Rajender; Naibedya Chattopadhyay
Journal:  Calcif Tissue Int       Date:  2021-02-09       Impact factor: 4.333

7.  Development of fatal colitis in FVB mice infected with Citrobacter rodentium.

Authors:  Diana Borenshtein; Prashant R Nambiar; Elizabeth B Groff; James G Fox; David B Schauer
Journal:  Infect Immun       Date:  2007-04-30       Impact factor: 3.441

8.  Melanin-concentrating hormone as a mediator of intestinal inflammation.

Authors:  Efi Kokkotou; Alan C Moss; Daniel Torres; Iordanes Karagiannides; Adam Cheifetz; Sumei Liu; Michael O'Brien; Eleftheria Maratos-Flier; Charalabos Pothoulakis
Journal:  Proc Natl Acad Sci U S A       Date:  2008-07-23       Impact factor: 11.205

9.  Pharmacological inhibition of NPY receptors illustrates dissociable features of experimental colitis in the mouse DSS model: Implications for preclinical evaluation of efficacy in an inflammatory bowel disease model.

Authors:  Henry H Ruiz; Stephanie Becker; Yu Bai; Luz A Cortes-Burgos; Melissa M Eckersdorff; Lynn E Macdonald; Susan D Croll
Journal:  PLoS One       Date:  2019-08-01       Impact factor: 3.240

10.  US Molecular Imaging of Acute Ileitis: Anti-Inflammatory Treatment Response Monitored with Targeted Microbubbles in a Preclinical Model.

Authors:  Huaijun Wang; Jean-Marc Hyvelin; Stephen A Felt; Ismayil Guracar; Jose G Vilches-Moure; Samir Cherkaoui; Thierry Bettinger; Lu Tian; Amelie M Lutz; Jürgen K Willmann
Journal:  Radiology       Date:  2018-07-24       Impact factor: 29.146

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.